Presentation is loading. Please wait.

Presentation is loading. Please wait.

An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis:

Similar presentations


Presentation on theme: "An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis:"— Presentation transcript:

1 An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials  P. Conaghan, V. Strand, D. Hunter, V.B. Kraus, F. Berenbaum, N.P. Katz, J. Lufkin, J.R. Johnson, S. Kelley, N. Bodick  Osteoarthritis and Cartilage  Volume 25, Pages S432-S433 (April 2017) DOI: /j.joca Copyright © Terms and Conditions

2 Figure 1 Proportions of OMERACT-OARSI “Strict” Responders (Pooled analyses, FAS). Osteoarthritis and Cartilage  , S432-S433DOI: ( /j.joca ) Copyright © Terms and Conditions


Download ppt "An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis:"

Similar presentations


Ads by Google